Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2022-09-01
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. The skin brightening effect of the product on facial skin.
2. To observe any adverse effect occurrence with the usage of the product.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Serum X
Participants will used serum X twice daily for 12 weeks
Other: Serum X
Serum X contain arbutin and glutathione
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Other: Serum X
Serum X contain arbutin and glutathione
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and female (age 18-30 years old)
Exclusion Criteria
* Participant who is taking isotretinoin, immunocompromised patients and received laser and light treatment within the last three months
* Participant who undergo whitening or cosmetic treatments such as botox and dermal fillers within the previous six month
* Participant with a history of facial surgery such as facelift or nose reshaping
* Participant with history of allergies to any ingredient in the study product
* Participant who is pregnant or plan to get pregnant
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Petaling Jaya, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMRAMREC001-22
Identifier Type: -
Identifier Source: org_study_id